Article Information
History
- June 2, 2020.
Article Versions
- You are currently viewing Version 1 of this article (June 2, 2020 - 09:06).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Han Eol Jeong, MPH1,†,
- Hyesung Lee, MS1,†,
- Hyun Joon Shin, MD2,
- Young June Choe, MD3,
- Kristian B. Filion, PhD4,5 and
- Ju-Young Shin, PhD1,6,*
- 1School of Pharmacy, Sungkyunkwan University, Suwon, Gyeonggi-do, South Korea
- 2Division of General Internal Medicine, Department of Medicine, Brigham and Women’s Hospital, Department of Global Health and Social Medicine, Harvard Medical School, Boston, MA, USA.
- 3Division of Infectious Diseases, Department of Social and Preventive Medicine, Hallym University College of Medicine, Chuncheon, Gangwon-do, South Korea
- 4Departments of Medicine and Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Quebec, Canada.
- 5Centre for Clinical Epidemiology, Lady Davis Institute, Montreal, Quebec, Canada
- 6Samsung Advanced Institute for Health Sciences & Technology, Sungkyunkwan University, Seoul, South Korea
- ↵*Corresponding author: Dr Ju-Young Shin School of Pharmacy, Sungkyunkwan University, 2066, Seobu-ro, Jangan-gu, Suwon, Gyeonggi-do 16419, South Korea Samsung Advanced Institute for Health Sciences & Technology, Sungkyunkwan University, 81 Irwon-ro, Gangnam-gu, Seoul 06351, South Korea Tel: +82-31-290-7702; E-mail: shin.jy{at}skku.edu
↵† These authors contributed equally to this work as co-first authors
Posted June 02, 2020.
Association between NSAIDs use and adverse clinical outcomes among adults hospitalised with COVID-19 in South Korea: A nationwide study
